Annual EBITDA
$4.97B$402.80M+8.82%
Summary
- Current Value
- As of today, VRTX annual EBITDA is $4.97B, up +8.82% on
- Historical Performance
- VRTX annual EBITDA is up +17.48% over the past 3 years, up +66.56% over the past 5 years
- All-Time High Comparison
- VRTX annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- VRTX annual EBITDA is +17.48% above its 3-year low of $4.23B reached on an earlier date
- Sector Comparison
- VRTX annual EBITDA is higher than 97.52% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $4.97B | +8.8% | +17.5% | +66.6% | +848.0% | |
| Quarterly EBITDA | $876.30M | -34.2% | -18.8% | -19.8% | +166.5% | |
| TTM EBITDA | $4.79B | +1.2% | +20.3% | +69.6% | +3553.4% | |
| Price | $537.79 | +23.9% | +53.4% | +185.7% | +1753.8% | |
| PE Ratio | 34.59 | +13.1% | +31.5% | +53.0% | – | |
| Annual Revenue | $12.07B | +9.9% | +38.0% | +94.5% | +8322.0% | |
| Annual EPS | $15.32 | +837.8% | +19.5% | +48.8% | +506.4% | |
| Annual EBIT | $4.69B | +7.5% | +14.9% | +63.1% | +774.9% | |
| Annual Net Income | $3.95B | +838.1% | +19.0% | +45.8% | +623.9% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $4.97B | at high | |
| 5Y | $4.97B | at high | |
| All | $4.97B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $4.23B | N/A | +17.5% |
| 5Y | $2.93B | +69.3% | |
| All | -$664.12M | +848.0% |
EBITDA History
FAQ
- What is the current annual EBITDA of VRTX?
- As of today, VRTX annual EBITDA is $4.97B
- What is 1-year change in VRTX annual EBITDA?
- VRTX annual EBITDA is up +8.82% year-over-year
- What is 3-year change in VRTX annual EBITDA?
- VRTX annual EBITDA is up +17.48% over the past 3 years
- How far is VRTX annual EBITDA from its all-time high?
- VRTX annual EBITDA is currently at its all-time high
- How does VRTX annual EBITDA rank versus sector peers?
- VRTX annual EBITDA is higher than 97.52% of companies in Healthcare sector
- When is VRTX next annual earnings release?
- The next annual earnings release for VRTX is on
EBITDA Formula
Quarterly EBITDA
$876.30M$459.10M-34.38%
Summary
- Current Value
- As of today, VRTX quarterly EBITDA is $876.30M, down -34.38% on
- Historical Performance
- VRTX quarterly EBITDA is down -34.20% year-over-year, down -18.76% over the past 3 years
- All-Time High Comparison
- VRTX quarterly EBITDA is currently -35.26% below its historical high of $1.35B set on
- 3-Year Low Comparison
- VRTX quarterly EBITDA is +125.25% above its 3-year low of -$3.47B reached on
- Sector Comparison
- VRTX quarterly EBITDA is higher than 96.21% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $876.30M | -34.4% | -34.2% | -18.8% | -19.8% | |
| Annual EBITDA | $4.97B | – | +8.8% | +17.5% | +66.6% | |
| TTM EBITDA | $4.79B | -8.7% | +1.2% | +20.3% | +69.6% | |
| Price | $537.79 | +4.3% | +23.9% | +53.4% | +185.7% | |
| PE Ratio | 34.59 | +15.3% | +13.1% | +31.5% | +53.0% | |
| Quarterly Revenue | $3.44B | +2.8% | +10.4% | +38.6% | +72.9% | |
| Quarterly EPS | $2.56 | -40.6% | -39.1% | -35.5% | -21.9% | |
| Quarterly EBIT | $1.25B | -2.1% | -2.0% | +20.8% | +18.0% | |
| Quarterly Net Income | $653.60M | -40.6% | -39.6% | -36.9% | -23.3% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.35B | -35.3% | |
| 3Y | $1.35B | -35.3% | |
| 5Y | $1.35B | -35.3% | |
| All | $1.35B | -35.3% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $876.30M | at low | |
| 3Y | -$3.47B | +125.3% | |
| 5Y | -$3.47B | +125.3% | |
| All | -$3.47B | +125.3% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of VRTX?
- As of today, VRTX quarterly EBITDA is $876.30M
- What is VRTX quarterly EBITDA most recent change?
- VRTX quarterly EBITDA was down -34.38% on September 30, 2026
- What is 1-year change in VRTX quarterly EBITDA?
- VRTX quarterly EBITDA is down -34.20% year-over-year
- How far is VRTX quarterly EBITDA from its all-time high?
- VRTX quarterly EBITDA is currently -35.26% below its historical high of $1.35B set on December 31, 2025
- How does VRTX quarterly EBITDA rank versus sector peers?
- VRTX quarterly EBITDA is higher than 96.21% of companies in Healthcare sector
- When is VRTX next earnings release?
- The next earnings release for VRTX is on
EBITDA Formula
TTM EBITDA
$4.79B$455.50M-8.69%
Summary
- Current Value
- As of today, VRTX TTM EBITDA is $4.79B, down -8.69% on
- Historical Performance
- VRTX TTM EBITDA is up +1.22% year-over-year, up +20.26% over the past 3 years
- All-Time High Comparison
- VRTX TTM EBITDA is currently -8.69% below its historical high of $5.24B set on
- 3-Year Low Comparison
- VRTX TTM EBITDA is +2723.57% above its 3-year low of -$182.40M reached on
- Sector Comparison
- VRTX TTM EBITDA is higher than 97.18% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $4.79B | -8.7% | +1.2% | +20.3% | +69.6% | |
| Annual EBITDA | $4.97B | – | +8.8% | +17.5% | +66.6% | |
| Quarterly EBITDA | $876.30M | -34.4% | -34.2% | -18.8% | -19.8% | |
| Price | $537.79 | +4.3% | +23.9% | +53.4% | +185.7% | |
| PE Ratio | 34.59 | +15.3% | +13.1% | +31.5% | +53.0% | |
| TTM Revenue | $13.02B | +2.5% | +11.0% | +36.1% | +81.3% | |
| TTM EPS | $15.55 | -9.6% | +9.6% | +16.7% | +86.7% | |
| TTM EBIT | $5.00B | -0.5% | +10.3% | +30.8% | +85.0% | |
| TTM Net Income | $3.98B | -9.8% | +8.2% | +14.6% | +82.7% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $5.24B | -8.7% | |
| 3Y | $5.24B | -8.7% | |
| 5Y | $5.24B | -8.7% | |
| All | $5.24B | -8.7% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $4.73B | N/A | +1.2% |
| 3Y | -$182.40M | +2723.6% | |
| 5Y | -$182.40M | +2723.6% | |
| All | -$664.12M | +820.6% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of VRTX?
- As of today, VRTX TTM EBITDA is $4.79B
- What is VRTX TTM EBITDA most recent change?
- VRTX TTM EBITDA was down -8.69% on September 30, 2026
- What is 1-year change in VRTX TTM EBITDA?
- VRTX TTM EBITDA is up +1.22% year-over-year
- How far is VRTX TTM EBITDA from its all-time high?
- VRTX TTM EBITDA is currently -8.69% below its historical high of $5.24B set on June 30, 2026
- How does VRTX TTM EBITDA rank versus sector peers?
- VRTX TTM EBITDA is higher than 97.18% of companies in Healthcare sector
- When is VRTX next earnings release?
- The next earnings release for VRTX is on
EBITDA Formula
Data Sources & References
- VRTX Official Website www.vrtx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/875320/000087532026000056/0000875320-26-000056-index.htm
- VRTX Profile on Yahoo Finance finance.yahoo.com/quote/VRTX
- VRTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vrtx
